Verity Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $911K | Sell |
19,688
-17,450
| -47% | -$808K | 0.44% | 58 |
|
|
2025
Q1 | $2.27M | Buy |
37,138
+18,931
| +104% | +$1.15M | 0.92% | 23 |
|
|
2024
Q4 | $1.01M | Sell |
18,207
-12,135
| -40% | -$674K | 0.57% | 48 |
|
|
2024
Q3 | $1.57M | Buy |
30,342
+14,694
| +94% | +$760K | 0.59% | 43 |
|
|
2024
Q2 | $650K | Buy |
15,648
+9,436
| +152% | +$392K | 0.25% | 89 |
|
|
2024
Q1 | $337K | Buy |
6,212
+315
| +5% | +$17.1K | 0.19% | 133 |
|
|
2023
Q4 | $303K | Buy |
5,897
+1,000
| +20% | +$51.3K | 0.19% | 131 |
|
|
2023
Q3 | $284K | Sell |
4,897
-914
| -16% | -$53K | 0.21% | 125 |
|
|
2023
Q2 | $372K | Sell |
5,811
-4,923
| -46% | -$315K | 0.28% | 98 |
|
|
2023
Q1 | $744K | Buy |
10,734
+5,417
| +102% | +$375K | 0.44% | 68 |
|
|
2022
Q4 | $383K | Sell |
5,317
-1,340
| -20% | -$96.4K | 0.33% | 98 |
|
|
2022
Q3 | $473K | Buy |
+6,657
| New | +$473K | 0.49% | 74 |
|
|
2022
Q1 | $464K | Buy |
+6,352
| New | +$464K | 0.29% | 104 |
|
|
2016
Q3 | $1.28M | Buy |
+23,682
| New | +$1.28M | 1.19% | 29 |
|